82 related articles for article (PubMed ID: 9212903)
21. In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue.
Iversen P
Anticancer Drug Des; 1991 Dec; 6(6):531-8. PubMed ID: 1772568
[TBL] [Abstract][Full Text] [Related]
22. Tissue disposition of 2'-O-(2-methoxy) ethyl modified antisense oligonucleotides in monkeys.
Yu RZ; Geary RS; Monteith DK; Matson J; Truong L; Fitchett J; Levin AA
J Pharm Sci; 2004 Jan; 93(1):48-59. PubMed ID: 14648635
[TBL] [Abstract][Full Text] [Related]
23. A rapid method for quantitation of oligodeoxynucleotide phosphorothioates in biological fluids and tissues.
Temsamani J; Kubert M; Agrawal S
Anal Biochem; 1993 Nov; 215(1):54-8. PubMed ID: 8297015
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species.
Geary RS; Yu RZ; Watanabe T; Henry SP; Hardee GE; Chappell A; Matson J; Sasmor H; Cummins L; Levin AA
Drug Metab Dispos; 2003 Nov; 31(11):1419-28. PubMed ID: 14570775
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice.
Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE
J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of coagulation by a phosphorothioate oligonucleotide.
Henry SP; Novotny W; Leeds J; Auletta C; Kornbrust DJ
Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):503-10. PubMed ID: 9361909
[TBL] [Abstract][Full Text] [Related]
27. Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice.
Zhao Q; Zhou R; Temsamani J; Zhang Z; Roskey A; Agrawal S
Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):451-8. PubMed ID: 9918109
[TBL] [Abstract][Full Text] [Related]
28. Rapid determination of the affinity of 28- and 14-mer phosphorothioate oligonucleotides for HIV-1 reverse transcriptase by fluorescence spectroscopy.
Maury G; Divita G; Morvan F; Imbach JL; Goody RS
Biochim Biophys Acta; 1993 Oct; 1216(1):1-8. PubMed ID: 7692972
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
[TBL] [Abstract][Full Text] [Related]
30. Optical antisense imaging of tumor with fluorescent DNA duplexes.
Liu X; Wang Y; Nakamura K; Liu G; Dou S; Kubo A; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2007; 18(6):1905-11. PubMed ID: 17939728
[TBL] [Abstract][Full Text] [Related]
31. Hydration of single-stranded phosphodiester and phosphorothioate oligodeoxyribonucleotides.
White AP; Reeves KK; Snyder E; Farrell J; Powell JW; Mohan V; Griffey RH
Nucleic Acids Res; 1996 Aug; 24(16):3261-6. PubMed ID: 8774910
[TBL] [Abstract][Full Text] [Related]
32. A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices.
Wei X; Dai G; Marcucci G; Liu Z; Hoyt D; Blum W; Chan KK
Pharm Res; 2006 Jun; 23(6):1251-64. PubMed ID: 16718617
[TBL] [Abstract][Full Text] [Related]
33. Binding of fluorescence- and gold-labeled oligodeoxyribonucleotides to cytoplasmic intermediate filaments in epithelial and fibroblast cells.
Hartig R; Huang Y; Janetzko A; Shoeman R; Grüb S; Traub P
Exp Cell Res; 1997 May; 233(1):169-86. PubMed ID: 9184086
[TBL] [Abstract][Full Text] [Related]
34. Electroporation-mediated delivery of 3'-protected phosphodiester oligodeoxynucleotides to the skin.
Regnier V; Tahiri A; André N; Lemaître M; Le Doan T; Préat V
J Control Release; 2000 Jul; 67(2-3):337-46. PubMed ID: 10825565
[TBL] [Abstract][Full Text] [Related]
35. Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioate, phosphorodithioate, and methylphosphonate oligonucleotides in nude mice.
DeLong RK; Nolting A; Fisher M; Chen Q; Wickstrom E; Kligshteyn M; Demirdji S; Caruthers M; Juliano RL
Antisense Nucleic Acid Drug Dev; 1997 Apr; 7(2):71-7. PubMed ID: 9149842
[TBL] [Abstract][Full Text] [Related]
36. Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.
Butler M; Stecker K; Bennett CF
Lab Invest; 1997 Oct; 77(4):379-88. PubMed ID: 9354772
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic and toxicity profile of a phosphorothioate oligonucleotide following inhalation delivery to lung in mice.
Templin MV; Levin AA; Graham MJ; Aberg PM; Axelsson BI; Butler M; Geary RS; Bennett CF
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):359-68. PubMed ID: 11079575
[TBL] [Abstract][Full Text] [Related]
38. Toxicological properties of several novel oligonucleotide analogs in mice.
Henry SP; Zuckerman JE; Rojko J; Hall WC; Harman RJ; Kitchen D; Crooke ST
Anticancer Drug Des; 1997 Jan; 12(1):1-14. PubMed ID: 9051110
[TBL] [Abstract][Full Text] [Related]
39. Transformed and immortalized cellular uptake of oligodeoxynucleoside phosphorothioates, 3'-alkylamino oligodeoxynucleotides, 2'-O-methyl oligoribonucleotides, oligodeoxynucleoside methylphosphonates, and peptide nucleic acids.
Gray GD; Basu S; Wickstrom E
Biochem Pharmacol; 1997 May; 53(10):1465-76. PubMed ID: 9260874
[TBL] [Abstract][Full Text] [Related]
40. Detection and quantitation of PS20, a phosphorothioate oligodeoxynucleotides in monkey plasma.
Shan MM; Song HF; Liu XW; Tang ZM
Acta Pharmacol Sin; 2004 Jun; 25(6):801-6. PubMed ID: 15169635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
